Biolux has brought together leading clinicians to speak about their experience using OrthoPulse®, patient results, and clinical tips for light accelerated treatment. Presentation topics include “Safely Moving Teeth Faster Combining OrthoPulse® and Invisalign®” and “A Paradigm Shift in Accelerated Orthodontics,” among others. Presenting doctors include Dr. Ron Redmond, USA; Dr. Todd Dickerson, USA; Dr. Hirohide Arimoto, Japan; Dr. Robert (Tito) Norris, USA; Dr. Tim Shaughnessy, USA; and Dr. Peter Brawn, Canada.
OrthoPulse® is a clinically proven device that uses low levels of light energy to stimulate the periodontium and alveolar bone surrounding the roots of the teeth and facilitate tooth movement. OrthoPulse® is the only device of its kind cleared by the FDA for use with both fixed appliances and clear aligners. It consists of a one-size-fits-all, soft, silicone mouth-guard that patients can use as an easy self-treatment for 10 minutes per day.
“We are excited to be highlighting the experiences of prominent doctors this year at the AAO and how they are successfully using OrthoPulse® in their practices,” states John Nabors, VP of Global Sales and Marketing. “Doctors are our connection to patients who are using OrthoPulse®. We have a great deal of clinical evidence and the AAO is the perfect place to showcase this.”
Visit www.orthopulse.com to view the OrthoPulse® AAO presentation schedule. Presentations will take place at booth #2121, Saturday, April 30th through Monday, May 2nd.
About Biolux Research
Biolux Research is a world leader in the development of innovative Light Accelerated OrthodonticsTM technology and products for use in orthodontics, implantology, and other dentistry markets. Biolux Research focuses on product development and clinical research, and its proprietary, patented technologies have been developed to enhance clinical outcomes and dramatically reduce treatment timelines in orthodontics and dentistry in a safe, effective and non-invasive approach. www.orthopulse.com www.bioluxresearch.com
For More Information:
Kevin Strange, President and CEO Biolux Research